Activity and safety of pegylated liposomal doxorubicin, 5-fluorouracil and folinic acid in inoperable hepatocellular carcinoma: A phase II study

AIM: To improve the results of New therapeutic strategies in hepatocellular carcinoma (HCC). We have conducted a phase II study with pegylated liposomal doxorubicin (PLD), 5-fluorouracil (5FU) and folinic acid (FA). METHODS: Thirty-one patients with hystologically-confirmed, inoperable HCC, received...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:World J Gastroenterol
Autori principali: Lorenzo, Giuseppe Di, Rea, Antonio, Carlomagno, Chiara, Pepe, Stefano, Palmieri, Giovannella, Labianca, Roberto, Chirianni, Antonio, Stefano, Alfonso De, Esposito, Vincenzo, Placido, Sabino De, Montesarchio, Vincenzo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Co., Limited 2007
Soggetti:
Rapid Communication
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4611295/
https://ncbi.nlm.nih.gov/pubmed/18161926
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v13.i48.6553
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi